These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 16450787)

  • 1. Immunohistochemical markers in the evaluation of tumors of the urinary bladder: a review.
    Emerson RE; Cheng L
    Anal Quant Cytol Histol; 2005 Dec; 27(6):301-16. PubMed ID: 16450787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical utility of immunohistochemistry in the diagnoses of urinary bladder neoplasia.
    Hodges KB; Lopez-Beltran A; Emerson RE; Montironi R; Cheng L
    Appl Immunohistochem Mol Morphol; 2010 Oct; 18(5):401-10. PubMed ID: 20505509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical markers in the evaluation of tumors of the urinary bladder: a review.
    Requena MJ; Alvarez-Kindelan J; Blanca A
    Anal Quant Cytol Histol; 2007 Dec; 29(6):380-2. PubMed ID: 18225396
    [No Abstract]   [Full Text] [Related]  

  • 4. The role of immunohistochemistry in the diagnosis of urinary bladder neoplasms.
    McKenney JK; Amin MB
    Semin Diagn Pathol; 2005 Feb; 22(1):69-87. PubMed ID: 16512600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary signet-ring cell carcinoma of the urinary bladder: a clinicopathologic and immunohistochemical study of 5 cases.
    Del Sordo R; Bellezza G; Colella R; Mameli MG; Sidoni A; Cavaliere A
    Appl Immunohistochem Mol Morphol; 2009 Jan; 17(1):18-22. PubMed ID: 18698262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical markers in evaluation of urinary and bladder tumors.
    Lopez-Beltran A
    Anal Quant Cytol Histol; 2007 Apr; 29(2):121-2. PubMed ID: 17484276
    [No Abstract]   [Full Text] [Related]  

  • 7. The applicability and utility of immunohistochemical biomarkers in bladder pathology.
    Akgul M; MacLennan GT; Cheng L
    Hum Pathol; 2020 Apr; 98():32-55. PubMed ID: 32035992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A case of a sporadic malignant peripheral nerve sheath tumor of the urinary bladder with concomitant in situ urothelial carcinoma treated by transuretheral resection.
    Sari A; Bal K; Tunakan M; Ozturk C
    Indian J Pathol Microbiol; 2011; 54(1):147-9. PubMed ID: 21393901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent advances in high-throughput molecular marker identification for superficial and invasive bladder cancers.
    Dyrskjot L; Zieger K; Orntoft TF
    Front Biosci; 2007 Jan; 12():2063-73. PubMed ID: 17127444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urothelial Carcinoma With Villoglandular Differentiation: A Rare Entity.
    Mitra S; Sundaram AK; Gupta K; Devana SK
    Int J Surg Pathol; 2016 Jun; 24(4):356-9. PubMed ID: 26721305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Morphological and Immunohistochemical Biomarkers in Distinguishing Prostate Carcinoma and Urothelial Carcinoma: A Comprehensive Review.
    Sanguedolce F; Russo D; Mancini V; Selvaggio O; Calò B; Carrieri G; Cormio L
    Int J Surg Pathol; 2019 Apr; 27(2):120-133. PubMed ID: 30509113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rhabdoid variant of urothelial carcinoma of the urinary bladder: a case report with emphasis on immunohistochemical analysis regarding the formation of rhabdoid morphology.
    Tajima S
    Int J Clin Exp Pathol; 2015; 8(8):9638-42. PubMed ID: 26464730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urothelial carcinoma of urinary bladder with exclusive heterologous component of epithelioid rhabdomyosarcoma at metastatic site.
    Agarwal P; Pasricha S; Gupta G; Sharma A; Mehta A
    Indian J Pathol Microbiol; 2018; 61(2):258-260. PubMed ID: 29676372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical expression of p63, p53 in urinary bladder carcinoma.
    Koyuncuer A
    Indian J Pathol Microbiol; 2013; 56(1):10-5. PubMed ID: 23924551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epithelial mesenchymal transition in urothelial carcinoma: twist in the tale.
    Paliwal P; Arora D; Mishra AK
    Indian J Pathol Microbiol; 2012; 55(4):443-9. PubMed ID: 23455777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Re: A prospective pilot evaluation of urinary and immunohistochemical markers as predictors of clinical stage of urothelial carcinoma of the bladder.
    Keegan PE
    BJU Int; 2000 Dec; 86(9):1096. PubMed ID: 11119116
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical, histological and immunohistochemical characteristics in patients with tumors of urinary bladder and renal failure.
    Buzulică R; Traşcă E; Nicolescu I; Stancu P; Traşcă ET
    Rom J Morphol Embryol; 2007; 48(2):145-50. PubMed ID: 17641801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical study of neuroendocrine differentiation in primary glandular lesions and tumors of the urinary bladder.
    Bollito ER; Pacchioni D; Lopez-Beltran A; Volante M; Terrone C; Casetta G; Mari M; DePompa R; Cappia S; Papotti M
    Anal Quant Cytol Histol; 2005 Aug; 27(4):218-24. PubMed ID: 16220833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A rare case of malignant paraganglioma of urinary bladder.
    Shah VB; Bhandare AT
    Indian J Pathol Microbiol; 2015; 58(2):235-7. PubMed ID: 25885144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Small cell carcinoma of the urinary bladder--histogenesis, genetics, diagnosis, biomarkers, treatment, and prognosis.
    Wang X; MacLennan GT; Lopez-Beltran A; Cheng L
    Appl Immunohistochem Mol Morphol; 2007 Mar; 15(1):8-18. PubMed ID: 17536302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.